Novo Nordisk's new CEO, Mike Doustdar, is under significant pressure as the company contends with declining stock prices, ...
BSE Midcap index rose 0.6 percent and smallcap index added 0.7 percent. On the sectoral front, pharma, telecom, realty, PSU Bank indices added 1-2 percent. Shriram Finance, M&M, Apollo Hospitals, SBI, ...
Agios maintains a robust balance sheet and is positioned for significant growth if regulatory approvals and market expansion ...
CRISPR Therapeutics is likely to witness an earnings beat as Casgevy sales climb and new CAR-T and in-vivo programs advance.
Vertex (VRTX) delivered earnings and revenue surprises of +5.49% and +1.14%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Find all the latest Q2 results 2025 updates of Bharti Airtel, Titan Company, Power Grid Corporation of India, Ambuja Cements, ...
On October 29, TD Cowen analyst Brendan Smith initiated coverage of West Pharmaceutical Services, Inc. (NYSE:WST) with a Buy rating and a price target of $350, as reported by The Fly.
Pfizer (PFE), one of the world’s oldest and most respected pharmaceutical companies, is currently facing significant stock ...
2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...
Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...
Novo Nordisk asserts its acquisition of Metsera won't pose antitrust problems as it competes with Pfizer for dominance in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback